Statements (29)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:Corticosteroid |
gptkbp:CASNumber |
516-54-1
|
gptkbp:drugClass |
benzodiazepine
sedative anticonvulsant |
gptkbp:effect |
positive allosteric modulator of GABAA receptor
|
gptkbp:hasBiologicalActivity |
neurosteroid
|
gptkbp:hasChEMBLId |
CHEMBL1407
|
gptkbp:hasDrugBankId |
DB01420
|
gptkbp:hasInChIKey |
GBBSUAFBMRNDJC-RKFFQIFLSA-N
|
gptkbp:hasMolecularFormula |
C21H34O2
|
gptkbp:hasSMILES |
C[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C(CCC(=O)CC4)[C@@H]3CC[C@]12C
|
gptkbp:hasUNII |
73R90F7MQ8
|
https://www.w3.org/2000/01/rdf-schema#label |
Tetrahydroprogesterone
|
gptkbp:isEndogenousTo |
gptkb:human
mammals |
gptkbp:IUPACName |
3α-hydroxy-5α-pregnan-20-one
|
gptkbp:meltingPoint |
162-163°C
|
gptkbp:metabolism |
gptkb:progesterone
|
gptkbp:predecessor |
gptkb:pregnanolone
|
gptkbp:producedBy |
reduction of progesterone
|
gptkbp:PubChem_CID |
9270
CHEBI:28923 |
gptkbp:synonym |
gptkb:THP
gptkb:allopregnanolone 3α-hydroxy-5α-pregnan-20-one |
gptkbp:bfsParent |
gptkb:THP
|
gptkbp:bfsLayer |
7
|